| 注册
首页|期刊导航|肿瘤药学|B7-H4和 CA125在卵巢癌早期诊断中的应用价值

B7-H4和 CA125在卵巢癌早期诊断中的应用价值

陈素梅

肿瘤药学Issue(2):104-106,3.
肿瘤药学Issue(2):104-106,3.DOI:10.3969/j.issn.2095-1264.2013.024

B7-H4和 CA125在卵巢癌早期诊断中的应用价值

Application Value of B7-H4 and CA125 in the Early Diagnosis of Ovarian Cancer

陈素梅1

作者信息

  • 1. 贺州市人民医院,广西 贺州,542800
  • 折叠

摘要

Abstract

Objective To analysis the application value of B7-H4 and CA125 in the early diagnosis of ovarian cancer. Methods The serum levels of B7-H4 and CA125 in ovarian cancer patients and healthy women were detected by ELISA double antibody sandwich assay. The relationship between the levels of B7-H4 and CA125 and ovarian cancer staging, treat-ment effect was analyzed and its value in the early diagnosis of ovarian cancer was evaluated. Results The serum B7-H4, CA125 molecular level of patients with ovarian cancer was significantly higher than those of healthy controls and increased with the stage of cancer (P<0.05). The serum level of B7-H4 and CA125 was related with ovarian cancer therapeutic effect. B7-H4 in combination with CA125 used in the diagnosis of ovarian cancer can significantly improve the diagnostic sensitivity and specificity. Conclusion B7-H4 and CA125 in combination used in the early diagnosis of ovarian cancer can significantly improve the sensitivity and specificity of the diagnosis. It is worthy of in-depth research and application.

关键词

卵巢癌/早期诊断/B7-H4/CA125

Key words

Ovarian cancer/Early diagnosis/B7-H4/CA125

分类

医药卫生

引用本文复制引用

陈素梅..B7-H4和 CA125在卵巢癌早期诊断中的应用价值[J].肿瘤药学,2013,(2):104-106,3.

肿瘤药学

2095-1264

访问量0
|
下载量0
段落导航相关论文